A5078104013- Venous Thromboembolism Diagnosis and Management
- Central Venous Catheters and Hemodialysis
- Aortic aneurysm repair treatments
- Peripheral Artery Disease Management
- Diagnosis and Treatment of Venous Diseases
- Cerebrovascular and Carotid Artery Diseases
- Vascular Procedures and Complications
- Radiology practices and education
- Radiation Dose and Imaging
- Cardiac, Anesthesia and Surgical Outcomes
- Aortic Disease and Treatment Approaches
- Hepatocellular Carcinoma Treatment and Prognosis
- Vascular anomalies and interventions
- Advanced X-ray and CT Imaging
- Liver Disease and Transplantation
- Cardiac Imaging and Diagnostics
- Renal and Vascular Pathologies
- Advanced MRI Techniques and Applications
- Hemodynamic Monitoring and Therapy
- Liver Disease Diagnosis and Treatment
- Acute Ischemic Stroke Management
- Ultrasound in Clinical Applications
- Infectious Aortic and Vascular Conditions
- Organ Transplantation Techniques and Outcomes
- Atrial Fibrillation Management and Outcomes
Oregon Health & Science University
2016-2025
University of Colorado Anschutz Medical Campus
2021
University of Colorado Hospital
2021
University of Colorado Denver
2021
University of Washington
2019
Oregon Health and Science University Hospital
2012-2018
Society of Interventional Radiology
2002-2018
Kōchi University
2015
Hiroshima University
2015
American Heart Association
2014
Abstract The abdominal aorta and renal, visceral, iliac arteries were evaluated in 16 patients with three‐dimensional Fourier transform imaging enhanced gadopentetate dimeglumine. By dynamically during the arterial phase of a 5‐minute injection (0.2 mmol/kg), highly significant ( P < .0001) preferential enhancement (signal‐to‐noise ratio ± standard deviation, 10 0.9), minimal inferior vena cava (5.1 1.4) or background tissues (fat, 4.3 0.7; muscle, 2.4 0.5), was achieved every patient. In...
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy endovascular therapy or surgical for CLTI superior improving outcomes.
Critical limb ischemia (CLI) is increasing in prevalence, and remains a significant source of mortality loss. The decision to recommend surgical or endovascular revascularization for patients who are candidates both varies significantly among providers driven more by individual preference than scientific evidence.The Best Endovascular Versus Surgical Therapy Patients With Limb Ischemia (BEST-CLI) Trial prospective, randomized, multidisciplinary, controlled, superiority trial designed compare...
Nontraumatic lower-extremity amputation is a devastating complication of peripheral artery disease (PAD) with high mortality and medical expenditure. There are ≈150 000 nontraumatic leg amputations every year in the United States, most cases occur patients diabetes. Among diabetes, after an ≈40% decline between 2000 2009, rate increased by 50% from 2009 to 2015. A number evidence-based diagnostic therapeutic approaches for PAD can reduce risk. However, their implementation adherence...
A prospective, blinded comparison of two-dimensional time-of-flight (TOF) magnetic resonance (MR) angiography and conventional arteriography was performed in 25 patients who underwent routine for symptomatic atherosclerotic occlusive disease the lower extremity. MR from distal abdominal aorta through popliteal trifurcation. The native arterial tree divided into nine segments; each segment assessed patency (defined as stenosis < 50% diameter), moderate (50%-69%), severe (70%-99%), or...
In the BEST-CLI trial (Best Endovascular Versus Best Surgical Therapy for Patients With Chronic Limb-Threatening Ischemia), a prespecified secondary objective was to assess effects of revascularization strategy on health-related quality life (HRQoL).